Commission Regulation (EU) 2018/1480 of 4 October 2018 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures and correcting Commission Regulation (EU) 2017/776 (Text with EEA relevance.)
Date: 2018-10-04
Institutions: Directorate-General for Environment, European Commission
Subjects: classification, dangerous substance, environmental protection, labelling, packaging, public health, technological change








L_2018251EN.01000101.xml










5.10.2018   


EN


Official Journal of the European Union


L 251/1








            COMMISSION REGULATION (EU) 2018/1480
of 4 October 2018
         
amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures and correcting Commission Regulation (EU) 2017/776
(Text with EEA relevance)


THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,


Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (1), and in particular Article 37(5) and Article 53(1) thereof,

Whereas:







(1)


Table 3.1 of Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains the list of harmonised classification and labelling of hazardous substances based on the criteria set out in Parts 2 to 5 of Annex I to that Regulation.












(2)


Proposals to introduce harmonised classification and labelling of certain substances and to update or delete the harmonised classification and labelling of certain other substances have been submitted to the European Chemicals Agency pursuant to Article 37 of Regulation (EC) No 1272/2008. Based on the opinions on those proposals issued by the Committee for Risk Assessment of the Agency (RAC), as well as on the comments received from the parties concerned, it is appropriate to introduce, update or delete harmonised classification and labelling of certain substances.












(3)


Council Directive 67/548/EEC (2) and Directive 1999/45/EC of the European Parliament and of the Council (3) were repealed with effect from 1 June 2015. As a result, Part 3 of Annex VI to Regulation (EC) No 1272/2008 was amended by Commission Regulation (EU) 2016/1179 (4) to remove Table 3.2. That amendment took effect on 1 June 2017. Annex VI to Regulation (EC) No 1272/2008 was further amended by Commission Regulation (EU) 2017/776 (5) to delete references to Table 3.2, to convert references to Table 3.1 into references to Table 3 and to delete references to the repealed Directives. Under Article 2(2) of Regulation (EU) 2017/776, the majority of those amendments were to apply from 1 June 2017, while the remaining amendments were stated to apply from 1 December 2018. However, due to an oversight, Article 2(2) failed to list two further amendments that should have applied from 1 June 2017, including in particular the amendment changing the name of the Table from ‘Table 3.1’ to ‘Table 3’. The second subparagraph of Article 2(2) of Regulation (EU) 2017/776 should therefore be corrected to include reference to those two amendments. This correction, although it has the effect of applying the two amendments retroactively, does not affect the rights and obligations of manufacturers, importers, downstream users or suppliers.












(4)


Regulation (EU) 2017/776 also amended Annex VI to Regulation (EC) No 1272/2008 to add harmonised ‘Acute Toxicity Estimate’ (ATE) values in Table 3.1 as part of the information relating to the classification and labelling of certain substances for the purposes of the classification of mixtures. The ATE introduced for nicotine was expressed in mg/kg. In order to clarify how mixtures containing nicotine should be classified, the ATE for the oral and the dermal routes for nicotine should instead be expressed in ‘mg/kg bw’ (6). The ATEs for three other substances, namely colecalciferol, 1,2-dihydroxybenzene and pinoxaden should also be expressed in the same way. In addition, in the title of the penultimate column of Table 3.1, a footnote should be added indicating what the abbreviation ‘mg/kg bw’ stands for.












(5)


The Annex to Commission Regulation (EU) 2018/669 (7) provides for the translation of the names of the substances included in Table 3.1 of Annex VI to Regulation (EC) No 1272/2008. As a consequence, the title of the second column of that Table, which currently refers to ‘international chemical identifications’, should be amended to take account of the fact that the ‘international chemical identifications’ will lose their international character once the Regulation providing for their translation in Annex VI becomes applicable. For the sake of consistency, this amendment should take effect when the translation of the names in Annex VI takes effect. The new title should reflect the terminology used in Article 18 of Regulation (EC) No 1272/2008.












(6)


Compliance with the new or updated harmonised classifications should not be required immediately as a certain period of time will be necessary to allow suppliers to adapt the labelling and packaging of substances and mixtures to the new or revised classifications and to sell existing stocks. That period of time will also be necessary to allow suppliers to adapt to and comply with other legislative obligations resulting from the new or updated harmonised classifications, such as those set out in Article 22(f) or Article 23 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council (8), those set out in Article 50 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (9) or those set out in Article 44 of Regulation (EC) No 1107/2009 of the European Parliament and of the Council (10).












(7)


Regulation (EC) No 1272/2008 should therefore be amended accordingly.












(8)


In line with the transitional provisions of Regulation (EC) No 1272/2008 which allow for new provisions to be applied at an earlier stage on a voluntary basis, suppliers should be allowed to apply the new and updated harmonised classifications, and to adapt the labelling and packaging accordingly, on a voluntary basis before the date of application of those new or updated classifications.












(9)


The measures provided for in this Regulation are in accordance with the opinion of the Committee established by Article 133 of Regulation (EC) No 1907/2006,





HAS ADOPTED THIS REGULATION:



Article 1

Amendment to Regulation (EC) No 1272/2008

Annex VI to Regulation (EC) No 1272/2008 is amended as set out in the Annex to this Regulation.


Article 2

Correction to Regulation (EU) 2017/776

In Regulation (EU) 2017/776, the second subparagraph of Article 2(2) is replaced by the following:

‘In the Annex, point (1), point (2) and points (a), (b) and (c) of point (3) shall apply from 1 June 2017.’



Article 3

Entry into force and application

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
Point (1) and point (a) of point (2) of the Annex shall apply from 1 December 2019.
Points (b), (c), (d) and (e) of point (2) of the Annex shall apply from 1 May 2020.
By way of derogation from the third paragraph of this Article, substances and mixtures may, before 1 May 2020, be classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008 as amended by this Regulation.




This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 4 October 2018.


For the Commission


The President

Jean-Claude JUNCKER
            





(1)  
            OJ L 353, 31.12.2008, p. 1.

(2)  Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (OJ 196, 16.8.1967, p. 1).

(3)  Directive 1999/45/EC of the European Parliament and of the Council of 31 May 1999 concerning the approximation of laws, regulations and administrative provisions of the Member States relating to the classification, packaging and labelling of dangerous preparations (OJ L 200, 30.7.1999, p. 1).

(4)  Commission Regulation (EU) 2016/1179 of 19 July 2016 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 195, 20.7.2016, p. 11).

(5)  Commission Regulation (EU) 2017/776 of 4 May 2017 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 116, 5.5.2017, p. 1).

(6)  Body weight.

(7)  Commission Regulation (EU) 2018/669 of 16 April 2018 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 115, 4.5.2018, p. 1).

(8)  Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006, p. 1).

(9)  Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (OJ L 167, 27.6.2012, p. 1).

(10)  Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (OJ L 309, 24.11.2009, p. 1).




ANNEX
Annex VI to Regulation (EC) No 1272/2008 is amended as follows:






(1)


in Part 1, the heading of point 1.1.1.4 is replaced by the following:

                        ‘
                        Chemical name
                        ’;










(2)


in Part 3, Table 3.1 is amended as follows:






(a)


the title of the second column is replaced by the following: ‘Chemical name’;










(b)


the title of the penultimate column is replaced by the following: ‘Specific Conc. Limits, M-factors and ATEs (*)






(*)


ATEs for oral and dermal exposure routes are expressed in mg/kg bw, which stands for milligram per kilogram bodyweight.’;














(c)


the entry corresponding to index number 607-414-00-6 is deleted;










(d)


the entries corresponding to index numbers 006-044-00-7, 015-101-00-5, 016-096-00-2, 017-011-00-1, 025-002-00-9, 603-180-00-4, 604-014-00-3, 604-016-00-4, 604-090-00-8, 605-003-00-6, 606-047-009, 607-096-00-9, 607-103-00-5, 607-113-00-X, 607-373-00-4, 613-167-00-5, 613-205-00-0 and 614-001-00-4 are replaced by the following entries respectively:















Index No


Chemical name


EC No


CAS No


Classification


Labelling


Specific Conc. Limits, M-factors and ATEs


Notes




Hazard Class and Category Code(s)


Hazard statement Code(s)


Pictogram, Signal Word Code(s)


Hazard statement Code(s)


Suppl. Hazard statement Code(s)




‘006-044-00-7


isoproturon (ISO);
3-(4-isopropylphenyl)-1,1-dimethylurea


251-835-4


34123-59-6


Carc. 2
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1


H351
H373 (blood)
H400
H410


GHS08
GHS09
Wng


H351
H373 (blood)
H410


 


M = 10
M = 10’


 




‘015-101-00-5


phosmet (ISO);

S-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl] O,O-dimethyl phosphorodithioate;

O,O-dimethyl-S-phthalimidomethyl phosphorodithioate


211-987-4


732-11-6


Repr. 2
Acute Tox. 4
Acute Tox. 3
STOT SE 1
Aquatic Acute 1
Aquatic Chronic 1


H361f
H332
H301
H370 (nervous system)
H400
H410


GHS08
GHS06
GHS09
Dgr


H361f
H332
H301
H370 (nervous system)
H410


 


M = 100
M = 100’


 




‘016-096-00-2


thifensulfuron-methyl (ISO);
methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate


—


79277-27-3


Aquatic Acute 1
Aquatic Chronic 1


H400
H410


GHS09
Wng


H410


 


M = 100
M = 100’


 




‘017-011-00-1


sodium hypochlorite, solution … % Cl active


231-668-3


7681-52-9


Skin Corr. 1B
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1


H314
H318
H400
H410


GHS05
GHS09
Dgr


H314
H410


EUH031


M = 10
M = 1
EUH031:
C ≥ 5 %


B’




‘025-002-00-9


potassium permanganate


231-760-3


7722-64-7


Ox. Sol. 2
Repr. 2
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1


H272
H361d
H302
H400
H410


GHS03
GHS08
GHS07
GHS09
Dgr


H272
H361d
H302
H410’


 


 


 




‘603-180-00-4


colecalciferol;
cholecalciferol;
vitamin D3



200-673-2


67-97-0


Acute Tox. 2 Acute Tox. 2 Acute Tox. 2
STOT RE 1


H330
H310
H300
H372


GHS06
GHS08
Dgr


H330
H310
H300
H372


 








 


inhalation:
ATE = 0,05 mg/L (dusts or mists)










 


dermal:
ATE = 50 mg/kg bw










 


oral:
ATE = 35 mg/kg bw
STOT RE 1; H372: C ≥ 3 %
STOT RE 2; H373: 0,3 % ≤ C < 3 %’






 




‘604-014-00-3


chlorocresol;
4-chloro-m-cresol;
4-chloro-3-methylphenol


200-431-6


59-50-7


Acute Tox. 4
Skin Corr. 1C
Eye Dam. 1
STOT SE 3
Skin Sens. 1B Aquatic Acute 1
Aquatic Chronic 3


H302
H314
H318
H335
H317
H400
H412


GHS07
GHS05
GHS09
Dgr


H302
H314
H335
H317
H410


 


M = 1’


 




‘604-016-00-4


1,2-dihydroxybenzene;
pyrocatechol


204-427-5


120-80-9


Carc. 1Β
Muta. 2
Acute Tox. 3
Acute Tox. 3
Skin Irrit. 2
Eye Irrit. 2


H350
H341
H311
H301
H315
H319


GHS08
GHS06
Dgr


H350
H341
H311
H301
H315
H319


 








 


oral:
ATE = 300 mg/kg bw










 


dermal:
ATE = 600 mg/kg bw’






 




‘604-090-00-8


4-tert-butylphenol


202-679-0


98-54-4


Repr. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 1


H361f
H315
H318
H410


GHS08
GHS05
GHS09
Dgr


H361f
H315
H318
H410


 


M = 1’


 




‘605-003-00-6


acetaldehyde;
ethanal


200-836-8


75-07-0


Flam. Liq. 1
Carc. 1B
Muta. 2
STOT SE 3
Eye Irrit. 2


H224
H350
H341
H335
H319


GHS02
GHS08
GHS07
Dgr


H224
H350
H341
H335
H319’


 


 


 




‘606-047-00-9


2-benzyl-2-dimethylamino-4′-morpholinobutyrophenone


404-360-3


119313-12-1


Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1


H360D
H400
H410


GHS08
GHS09
Dgr


H360D
H410’


 


 


 




‘607-096-00-9


maleic anhydride


203-571-6


108-31-6


Acute Tox. 4
STOT RE 1
Skin Corr. 1B
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1A


H302
H372 (respiratory system) (inhalation)
H314
H318
H334
H317


GHS07
GHS08
GHS05
Dgr


H302
H372 (respiratory system) (inhalation)
H314
H334
H317


EUH071


Skin Sens. 1A; H317: C ≥ 0,001 %’


 




‘607-103-00-5


succinic anhydride


203-570-0


108-30-5


Acute Tox. 4
Skin Corr. 1
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1


H302
H314
H318
H334
H317


GHS07
GHS05
GHS08
Dgr


H302
H314
H334
H317


EUH071’


 


 




‘607-113-00-X


isobutyl methacrylate


202-613-0


97-86-9


Flam. Liq. 3
STOT SE 3
Skin Irrit. 2
Skin Sens. 1B


H226
H335
H315
H317


GHS02
GHS07
Wng


H226
H335
H315
H317


 


 


D’




‘607-373-00-4


quizalofop-P-tefuryl (ISO); (+/–) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate


414-200-4


200509-41-7


Carc. 2
Repr. 2
Acute Tox. 4
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1


H351
H361fd
H302
H373
H400
H410


GHS08
GHS07
GHS09
Wng


H351
H361fd
H302
H373
H410


 


M = 1
M = 1’


 




‘613-167-00-5


reaction mass of 5-chloro-2-methyl-2H-isothiazol-3-one and 2-methyl-2H-isothiazol-3-one (3:1)


—


55965-84-9


Acute Tox. 2
Acute Tox. 2
Acute Tox. 3
Skin Corr. 1C
Eye Dam. 1
Skin Sens. 1A Aquatic Acute 1
Aquatic Chronic 1


H330
H310
H301
H314
H318
H317
H400
H410


GHS06
GHS05
GHS09
Dgr


H330
H310
H301
H314
H317
H410


EUH071


Skin Corr. 1C; H314: C ≥ 0,6 %
Skin Irrit. 2; H315: 0,06 % ≤ C < 0,6 %
Eye Dam. 1; H318: C ≥ 0,6 %
Eye Irrit. 2; H319: 0,06 % ≤ C < 0,6 %
Skin Sens. 1A; H317: C ≥ 0,0015 %
M = 100
M = 100


B’




‘613-205-00-0


propiconazole (ISO); (2RS,4RS;2RS,4SR)-1-{[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl}-1H-1,2,4-triazole


262-104-4


60207-90-1


Repr. 1B
Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1


H360D
H302
H317
H400
H410


GHS08
GHS07
GHS09
Dgr


H360D
H302
H317
H410


 


M = 1
M = 1’


 




‘614-001-00-4


nicotine (ISO);
3-[(2S)-1-methylpyrrolidin-2-yl]pyridine


200-193-3


54-11-5


Acute Tox. 2
Acute Tox. 2
Acute Tox. 2
Aquatic Chronic 2


H330
H310
H300
H411


GHS06
GHS09
Dgr


H330
H310
H300
H411


 








 


inhalation:
ATE = 0,19 mg/L (dusts or mists)










 


dermal:
ATE = 70 mg/kg bw










 


oral:
ATE = 5 mg/kg bw’






 














(e)


the following entries are inserted in the appropriate places, following the order of the entries set out in Table 3.1:















Index No


Chemical name


EC No


CAS No


Classification


Labelling


Specific Conc. Limits, M-factors and ATEs


Notes




Hazard Class and Category Code(s)


Hazard statement Code(s)


Pictogram, Signal Word Code(s)


Hazard statement Code(s)


Suppl. Hazard statement Code(s)




‘604-094-00-X


isoeugenol; [1]
(E)-2-methoxy-4-(prop-1-enyl)phenol; [2]
(Z)-2-methoxy-4-(prop-1-enyl)phenol [3]


202-590-7 [1]
227-678-2 [2]
227-633-7 [3]


97-54-1 [1]
5932-68-3 [2]
5912-86-7 [3]


Skin Sens. 1A


H317


GHS07
Wng


H317


 


Skin Sens. 1A; H317: C ≥ 0,01 %’


 




‘607-724-00-1


2,3,5,6-tetrafluoro-4-(methoxymethyl)benzyl (1R,3R)-2,2-dimethyl-3-[(1Z)-prop-1-en-1-yl]cyclopropanecarboxylate; epsilon-metofluthrin


—


240494-71-7


Acute Tox. 4
Acute Tox. 3
STOT SE 1
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1


H332
H301
H370 (nervous system)
H373
H400
H410


GHS06
GHS08
GHS09
Dgr


H332
H301
H370 (nervous system)
H373
H410


 


M = 100
M = 100’


 




‘607-725-00-7


isopropyl (2E,4E,7S)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate; S-methoprene


—


65733-16-6


Aquatic Acute 1
Aquatic Chronic 1


H400
H410


GHS09
Wng


H410


 


M = 1
M = 1’


 




‘607-726-00-2


pinoxaden (ISO);
8-(2,6-diethyl-4-methylphenyl)-7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoate


—


243973-20-8


Repr. 2
Acute Tox. 4
Acute Tox. 4
Eye Irrit. 2
STOT SE 3
Skin Sens. 1A
Aquatic Acute 1
Aquatic Chronic 3


H361d
H332
H302
H319
H335
H317
H400
H412


GHS08
GHS07
GHS09
Wng


H361d
H332
H302
H319
H335
H317
H410


 








 


inhalation:
ATE = 4,63 mg/L (dusts or mists)










 


oral:
ATE = 500 mg/kg bw
M = 1’






 




‘607-727-00-8


tetramethrin (ISO);
(1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl)methyl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate


231-711-6


7696-12-0


Carc. 2
Acute Tox. 4
STOT SE 2
Aquatic Acute 1
Aquatic Chronic 1


H351
H302
H371 (nervous system) (inhalation)
H400
H410


GHS08
GHS07
GHS09
Wng


H351
H302
H371 (nervous system) (inhalation)
H410


 


M = 100
M = 100’


 




‘607-728-00-3


(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate


214-619-0


1166-46-7


Carc. 2
Acute Tox. 4
STOT SE 2
Aquatic Acute 1
Aquatic Chronic 1


H351
H302
H371 (nervous system) (inhalation)
H400
H410


GHS08
GHS07
GHS09
Wng


H351
H302
H371 (nervous system) (inhalation)
H410


 


M = 100
M = 100’


 




‘607-729-00-9


mesosulfuron-methyl (ISO);
methyl 2-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-α-(methanesulfonamido)-p-toluate;


—


208465-21-8


Aquatic Acute 1
Aquatic Chronic 1


H400
H410


GHS09
Wng


H410


 


M = 100
M = 100’


 




‘607-730-00-4


spirodiclofen (ISO);
3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate


—


148477-71-8


Carc. 1B
Repr. 2
STOT RE 2
Skin Sens. 1B
Aquatic Chronic 1


H350
H361f
H373
H317
H410


GHS08
GHS07
GHS09
Dgr


H350
H361f
H373
H317
H410


 


M = 10’


 




‘607-731-00-X


sodium methyl [(4-aminophenyl)sulphonyl]carbamate; sodium methyl (EZ)-sulfanilylcarbonimidate; asulam-sodium


218-953-8


2302-17-2


Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1


H317
H400
H410


GHS07
GHS09
Wng


H317
H410


 


M = 1
M = 1’


 




‘607-732-00-5


salicylic acid


200-712-3


69-72-7


Repr. 2
Acute Tox. 4
Eye Dam. 1


H361d
H302
H318


GHS08
GHS07
GHS05
Dgr


H361d
H302
H318’


 


 


 




‘608-068-00-9


flutianil (ISO);
(2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methoxyphenyl)-1,3-thiazolidin-2-ylidene]acetonitrile


—


958647-10-4


Aquatic Chronic 1


H410


GHS09
Wng


H410


 


M = 100’


 




‘612-293-00-8


reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy)but-2-ylamine


447-920-2


-


Repr. 2
Acute Tox. 4
Skin Corr. 1B
Eye Dam. 1


H361f
H302
H314
H318


GHS08
GHS07
GHS05
Dgr


H361f
H302
H314


EUH071’


 


 




‘613-326-00-9


2-methylisothiazol-3(2H)-one


220-239-6


2682-20-4


Acute Tox. 2
Acute Tox. 3
Acute Tox. 3
Skin Corr. 1B
Eye Dam. 1
Skin Sens. 1A
Aquatic Acute 1
Aquatic Chronic 1


H330
H311
H301
H314
H318
H317
H400
H410


GHS05
GHS06
GHS09
Dgr


H330
H311
H301
H314
H317
H410


EUH071


Skin Sens. 1A; H317: C ≥ 0,0015 %
M = 10
M = 1’


 




‘613-327-00-4


pyroxsulam (ISO);

N-(5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-methoxy-4-(trifluoromethyl)pyridine-3-sulfonamide


—


422556-08-9


Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1


H317
H400
H410


GHS07
GHS09
Wng


H317
H410


 


M = 100
M = 100’


 




‘613-328-00-X


1-vinylimidazole


214-012-0


1072-63-5


Repr. 1B


H360D


GHS08
Dgr


H360D


 


Repr. 1B; H360D: C ≥ 0,03 %’


 




‘616-224-00-2


amisulbrom (ISO);
3-(3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamide


—


348635-87-0


Carc. 2
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1


H351
H319
H400
H410


GHS08
GHS07
GHS09
Wng


H351
H319
H410


 


M = 10
M = 10’